Cargando…
RTS,S/AS01 malaria vaccine (Mosquirix(®)): a profile of its use
RTS,S/AS01 (Mosquirix(®)) is a vaccine against malaria caused by Plasmodium falciparum. In a phase 3 trial, RTS,S/AS01 showed vaccine efficacy against clinical malaria, severe malaria and malaria hospitalization, with an acceptable safety and tolerability profile, in children aged 6 weeks to 17 mont...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449949/ https://www.ncbi.nlm.nih.gov/pubmed/36093265 http://dx.doi.org/10.1007/s40267-022-00937-3 |